IL6 and myocardial infarction: In another study by Lan et al., in patients with myocardial infarction, a statistically significant decrease in IL-6 at the end of three months of treatment with ticagrelor from baseline was reported (from 162.31 ± 33.41 ng/mL to 103.44 ± 12.54 ng/mL).